Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

See-Tarn Woon

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Pathology|November 16, 2023
Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotypingSee-Tarn Woon, Felicia Tjandra, John Mackay, et al.
Journal of Clinical Immunology|August 31, 2015
Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing EnteropathyRohan Ameratunga, Russell William Barker, Richard Henderson Steele, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Oncology Research|February 24, 2006
A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell linesSee-Tarn Woon, Charu B Reddy, Catherine J Drummond, et al.
Clinical & Translational Immunology|February 27, 2024
Phenotypic spectrum in a family with a novel <i>RAC2</i> p.I21S dominant-activating mutationLouisa Ashby, Lydia Chan, Christine Winterbourn, et al.
Clinical Immunology (Orlando, Fla.)|November 28, 2023
Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospectsRohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|September 17, 2021
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
Journal of Medicinal Chemistry|July 10, 2007
Synthesis and biological activity of azido analogues of 5,6-dimethylxanthenone-4-acetic acid for use in photoaffinity labelingBrian D Palmer, Kimiora Henare, See-Tarn Woon, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Pathology|November 16, 2023
Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotypingSee-Tarn Woon, Felicia Tjandra, John Mackay, et al.
Journal of Clinical Immunology|August 31, 2015
Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing EnteropathyRohan Ameratunga, Russell William Barker, Richard Henderson Steele, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Oncology Research|February 24, 2006
A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell linesSee-Tarn Woon, Charu B Reddy, Catherine J Drummond, et al.
Clinical & Translational Immunology|February 27, 2024
Phenotypic spectrum in a family with a novel <i>RAC2</i> p.I21S dominant-activating mutationLouisa Ashby, Lydia Chan, Christine Winterbourn, et al.
Clinical Immunology (Orlando, Fla.)|November 28, 2023
Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospectsRohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|September 17, 2021
Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
Journal of Medicinal Chemistry|July 10, 2007
Synthesis and biological activity of azido analogues of 5,6-dimethylxanthenone-4-acetic acid for use in photoaffinity labelingBrian D Palmer, Kimiora Henare, See-Tarn Woon, et al.
Pageof 7